The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40

BACKGROUND: NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoints included rates of surgical complications after surgery in patients who did or did not receive bev. METHODS: 1206 women with HER2-negativ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Bear, Harry D., Tang, Gong, Rastogi, Priya, Geyer, Charles E., Zoon, Christine K., Kidwell, Kelley M., Robidoux, André, Baez-Diaz, Luis, Brufsky, Adam M., Mehta, Rita S., Fehrenbacher, Louis, Young, James A., Senecal, Francis M., Gaur, Rakesh, Margolese, Richard G., Adams, Paul T., Gross, Howard M., Costantino, Joseph P., Paik, Soonmyung, Swain, Sandra M., Mamounas, Eleftherios P., Wolmark, Norman
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821429/
https://ncbi.nlm.nih.gov/pubmed/27864694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5662-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky